China Sepsis Diagnostics Market Size & Outlook, 2022-2030
China sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
China sepsis diagnostics market highlights
- The China sepsis diagnostics market generated a revenue of USD 32.2 million in 2022 and is expected to reach USD 77.2 million by 2030.
- The China market is expected to grow at a CAGR of 11.6% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 32.2 million |
| Market revenue in 2030 | USD 77.2 million |
| Growth rate | 11.6% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, China accounted for 3.2% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 77.2 million by 2030.
Blood culture media was the largest segment with a revenue share of 39.13% in 2022. Horizon Databook has segmented the China sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The market in China is expected to grow rapidly due to an increasing incidence of sepsis, an aging population, and improved healthcare infrastructure. In 2020, sepsis was identified as a major health concern in China, accounting for around 986,929 deaths and contributing to 17.1 million years of life lost.
This data highlights the severe impact of sepsis on public health and underscores the urgent need for effective prevention, early detection, and treatment strategies to address this critical issue. According to the study published in the National Library of Medicine, in October 2022, Sepsis is prevalent in 25.5% of ICU patients in China.
Several companies are operating in the sepsis diagnostics market including Roche Diagnostics, bioMérieux, and Thermo Fisher Scientific. These companies offer a range of sepsis diagnostic tests & medical devices, including biomarker-based assays, molecular diagnostic tests, and point-of-care testing devices.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China sepsis diagnostics market size, by product, 2018-2030 (US$M)
China Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
